Skip to main content
Top
Published in: Journal of the International AIDS Society 1/2010

Open Access 01-12-2010 | Research

Kidney function of HIV-infected children in Lagos, Nigeria: using Filler's serum cystatin C-based formula

Authors: Christopher I Esezobor, Edna Iroha, Olajumoke Oladipo, Elizabeth Onifade, Oyetunji O Soriyan, Adebola O Akinsulie, Edamisan O Temiye, Chinyere Ezeaka

Published in: Journal of the International AIDS Society | Issue 1/2010

Login to get access

Abstract

Background

Limited data is available on kidney function in HIV-infected children in sub-Saharan Africa. In addition, malnutrition in these children further reduces the utility of diagnostic methods such as creatinine-based estimates of glomerular filtration rate. We determined the serum cystatin C level and estimated glomerular filtration rate of 60 antiretroviral-naïve, HIV-infected children and 60 apparently healthy age and sex matched children.

Methods

Serum cystatin C level was measured using enzyme-linked immunosorbent assay technique, while glomerular filtration rate was estimated using Filler's serum cystatin C formula. Student t test, Mann Whitney U test, Pearson chi square and Fisher's exact test were used, where appropriate, to test difference between groups.

Results

Compared to the controls, the HIV-infected group had significantly higher median (interquartile range) serum cystatin C levels {0.77 (0.29) mg/l versus 0.66 (0.20) mg/l; p = 0.025} and a higher proportion of children with serum cystatin C level >1 mg/l {10 (16.7%) versus one (1.7%); p = 0.004}. The HIV-infected children had a mean (± SD) eGFR of 96.8 (± 36.1) ml/min/1.73 m2 compared with 110.5 (± 27.8) ml/min/1.73 m2 in the controls (p = 0.021). After controlling for age, sex and body mass index, only the study group (HIV infected versus control) remained a significant predictor of serum cystatin C level (β = -0.216, p = 0.021). The proportion of HIV-infected children with eGFR <60 ml/min/1.73 m2 was eight (13.3%) versus none (0%) in the control group (p = 0.006). However, the serum cystatin C level, eGFR and proportions of children with serum cystatin C level >1 mg/l and eGFR <60 ml/min/1.73 m2 were not significantly different between the HIV-infected children with advanced disease and those with milder disease.

Conclusions

HIV-infected children in Nigeria have higher serum cystatin C level and lower eGFR compared to age and sex matched controls.
Literature
1.
go back to reference Cohen SD, Kimmel PL: HIV-associated renal disease in Africa - a desperate need for additional study. Nephrol Dial Transplant 2007, 22:2116–2119.CrossRefPubMed Cohen SD, Kimmel PL: HIV-associated renal disease in Africa - a desperate need for additional study. Nephrol Dial Transplant 2007, 22:2116–2119.CrossRefPubMed
2.
go back to reference Kimmel PL, Barisoni L, Kopp JB: Pathogenesis and Treatment of HIV-Associated Renal Diseases: Lessons from Clinical and Animal Studies, Molecular Pathologic Correlations and Genetic Investigations. Ann Intern Med 2003, 139:218–220. Kimmel PL, Barisoni L, Kopp JB: Pathogenesis and Treatment of HIV-Associated Renal Diseases: Lessons from Clinical and Animal Studies, Molecular Pathologic Correlations and Genetic Investigations. Ann Intern Med 2003, 139:218–220.
3.
4.
go back to reference Stevens LA, Coresh J, Greene T, Levey AS: Assessing kidney function: measured and estimated glomerular filtration rate. N Engl J Med 2006, 354:2473–2483.CrossRefPubMed Stevens LA, Coresh J, Greene T, Levey AS: Assessing kidney function: measured and estimated glomerular filtration rate. N Engl J Med 2006, 354:2473–2483.CrossRefPubMed
5.
go back to reference Odden MC, Scherzer R, Bacchetti P, Szczech LA, Sidney S, Grunfeld C, Shlipak MG: Cystatin C level as a marker of kidney function in human immunodeficiency virus infection. The FRAM Study. Arch Intern Med 2007, 167:2213–2219.CrossRefPubMed Odden MC, Scherzer R, Bacchetti P, Szczech LA, Sidney S, Grunfeld C, Shlipak MG: Cystatin C level as a marker of kidney function in human immunodeficiency virus infection. The FRAM Study. Arch Intern Med 2007, 167:2213–2219.CrossRefPubMed
6.
go back to reference Afolabi MO, Abioye-Kuteyi EA, Arogundade FA, Bello IS: Prevalence of chronic kidney disease in a Nigerian family practice population. SA Fam Pract 2009, 51:132–137. Afolabi MO, Abioye-Kuteyi EA, Arogundade FA, Bello IS: Prevalence of chronic kidney disease in a Nigerian family practice population. SA Fam Pract 2009, 51:132–137.
7.
go back to reference Arpadi SM: Growth failure in children with HIV infection. J Acquir Immune Defic Syndr 2000,25(suppl 1):37–42.CrossRef Arpadi SM: Growth failure in children with HIV infection. J Acquir Immune Defic Syndr 2000,25(suppl 1):37–42.CrossRef
8.
go back to reference Jones CY, Jones CA, Wilson IB, Knox TA, Levey AS, Spiegelman D, Gorbach SL, Van Lente F, Stevens LA: Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study. Am J Kidney Dis 2008, 51:914–924.CrossRefPubMed Jones CY, Jones CA, Wilson IB, Knox TA, Levey AS, Spiegelman D, Gorbach SL, Van Lente F, Stevens LA: Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study. Am J Kidney Dis 2008, 51:914–924.CrossRefPubMed
9.
go back to reference Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J: Cystatin C- A new marker of glomerular filtration rate in children independent of age and height. Pediatrics 1998, 101:875–881.CrossRefPubMed Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J: Cystatin C- A new marker of glomerular filtration rate in children independent of age and height. Pediatrics 1998, 101:875–881.CrossRefPubMed
10.
go back to reference Laterza OF, Price CP, Scott MG: Cystatin C: An improved estimator of glomerular filtration rate? Clin Chem 2002, 48:699–707.PubMed Laterza OF, Price CP, Scott MG: Cystatin C: An improved estimator of glomerular filtration rate? Clin Chem 2002, 48:699–707.PubMed
11.
go back to reference Filler G, Lepage N: Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol 2003, 18:981–5.CrossRefPubMed Filler G, Lepage N: Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol 2003, 18:981–5.CrossRefPubMed
12.
go back to reference White C, Akbari A, Hussain N, Dinh L, Filler G, Lepage N, Knoll GA: Estimating glomerular filtration rate in kidney transplantation: a comparison between serum creatinine and cystatin C-based methods. J Am Soc Nephrol 2005, 16:3763–3770.CrossRefPubMed White C, Akbari A, Hussain N, Dinh L, Filler G, Lepage N, Knoll GA: Estimating glomerular filtration rate in kidney transplantation: a comparison between serum creatinine and cystatin C-based methods. J Am Soc Nephrol 2005, 16:3763–3770.CrossRefPubMed
13.
go back to reference WHO: Interim WHO clinical staging of HIV/AIDS and HIV/AIDS case definitions for surveillance. Geneva. 2005. WHO: Interim WHO clinical staging of HIV/AIDS and HIV/AIDS case definitions for surveillance. Geneva. 2005.
15.
go back to reference Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C: Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005,352(20):2049–2060.CrossRefPubMed Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C: Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005,352(20):2049–2060.CrossRefPubMed
16.
go back to reference Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS: Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 2006,145(4):237–246.PubMed Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS: Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 2006,145(4):237–246.PubMed
17.
go back to reference Jaroszewicz J, Wiercinska-Drapalo A, Lapinski TW, Prokopowicz D, Rogalska M, Parfieniuk A: Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART duration. Antivir Ther 2006, 11:641–645.PubMed Jaroszewicz J, Wiercinska-Drapalo A, Lapinski TW, Prokopowicz D, Rogalska M, Parfieniuk A: Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART duration. Antivir Ther 2006, 11:641–645.PubMed
18.
19.
go back to reference Baxmann AC, Ahmed MS, Marques NC, Menon VB, Pereira AB, Kirsztajn GM, Heilberg IP: Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol 2008, 3:348–354.CrossRefPubMed Baxmann AC, Ahmed MS, Marques NC, Menon VB, Pereira AB, Kirsztajn GM, Heilberg IP: Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol 2008, 3:348–354.CrossRefPubMed
20.
go back to reference Finney H, Newman DJ, Thakkar H, Fell JME, Price CP: Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates and older children. Arch Dis Child 2000, 82:71–75.CrossRefPubMed Finney H, Newman DJ, Thakkar H, Fell JME, Price CP: Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates and older children. Arch Dis Child 2000, 82:71–75.CrossRefPubMed
21.
go back to reference Sharma AP, Kathiravelu A, Nadarajah R, Yasin A, Filler G: Body mass does not have a clinically relevant effect on cystatin C eGFR in children. Nephrol Dial Transplant 2009,24(2):470–474.CrossRefPubMed Sharma AP, Kathiravelu A, Nadarajah R, Yasin A, Filler G: Body mass does not have a clinically relevant effect on cystatin C eGFR in children. Nephrol Dial Transplant 2009,24(2):470–474.CrossRefPubMed
22.
go back to reference Muntner P, Winston J, Uribarri J, Mann D, Fox CS: Overweight, obesity, and elevated serum cystatin C levels in adults in the United States. Am J Med 2008, 121:341–348.CrossRefPubMed Muntner P, Winston J, Uribarri J, Mann D, Fox CS: Overweight, obesity, and elevated serum cystatin C levels in adults in the United States. Am J Med 2008, 121:341–348.CrossRefPubMed
23.
go back to reference Knight EL, Verhave JC, Spiegelman D, Hillege HL, De Zeeuw D, Curhan GC, De Jong PE: Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004, 65:1416–1421.CrossRefPubMed Knight EL, Verhave JC, Spiegelman D, Hillege HL, De Zeeuw D, Curhan GC, De Jong PE: Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004, 65:1416–1421.CrossRefPubMed
24.
go back to reference Esezobor CI, Iroha E, Onifade E, Akinsulie AO, Temiye EO, Ezeaka C: Prevalence of proteinuria among HIV-infected children attending a tertiary hospital in Lagos, Nigeria. J Trop Pediatr 2009, in press. Esezobor CI, Iroha E, Onifade E, Akinsulie AO, Temiye EO, Ezeaka C: Prevalence of proteinuria among HIV-infected children attending a tertiary hospital in Lagos, Nigeria. J Trop Pediatr 2009, in press.
25.
go back to reference Chaparro AI, Mitchell CD, Abitbol CL, Wilkinson JD, Baldarrago G, Lopez E, Zilleruelo G: Proteinuria in children infected with the human immunodeficiency virus. J Pediatr 2008, 152:844–849.CrossRefPubMed Chaparro AI, Mitchell CD, Abitbol CL, Wilkinson JD, Baldarrago G, Lopez E, Zilleruelo G: Proteinuria in children infected with the human immunodeficiency virus. J Pediatr 2008, 152:844–849.CrossRefPubMed
26.
go back to reference Eke FU, Anochie IC, Okpere AN, Ugboma H: Proteinuria in HIV positive children- a pilot study [abstract]. Pediatr Nephrol 2007, 1456. Eke FU, Anochie IC, Okpere AN, Ugboma H: Proteinuria in HIV positive children- a pilot study [abstract]. Pediatr Nephrol 2007, 1456.
27.
go back to reference Wools-Kaloustian K, Gupta SK, Muloma E, Owino-Ong'or W, Sidle J, Aubrey RW, Shen J, Kipruto K, Zwickl BE, Goldman M: Renal disease in an antiretroviral-naïve HIV-infected outpatient population in western Kenya. Nephrol Dial Transplant 2007, 22:2208–2212.CrossRefPubMed Wools-Kaloustian K, Gupta SK, Muloma E, Owino-Ong'or W, Sidle J, Aubrey RW, Shen J, Kipruto K, Zwickl BE, Goldman M: Renal disease in an antiretroviral-naïve HIV-infected outpatient population in western Kenya. Nephrol Dial Transplant 2007, 22:2208–2212.CrossRefPubMed
28.
go back to reference Gupta SK, Eustace JA, Wiston JA, Boydstun II, Ahuja TS, Rodriguez RA, Tashima KT, Roland M, Francesschini N, Palella FJ, Lennox JL, Klotman PE, Nachman SA, Hall SD, Szczech LA: Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2005, 40:1559–1585.CrossRefPubMed Gupta SK, Eustace JA, Wiston JA, Boydstun II, Ahuja TS, Rodriguez RA, Tashima KT, Roland M, Francesschini N, Palella FJ, Lennox JL, Klotman PE, Nachman SA, Hall SD, Szczech LA: Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2005, 40:1559–1585.CrossRefPubMed
29.
go back to reference Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, Froissart M, Kusek JW, Zhang Y, Coresh J, Levey AS: Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009, 75:652–660.CrossRefPubMed Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, Froissart M, Kusek JW, Zhang Y, Coresh J, Levey AS: Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009, 75:652–660.CrossRefPubMed
Metadata
Title
Kidney function of HIV-infected children in Lagos, Nigeria: using Filler's serum cystatin C-based formula
Authors
Christopher I Esezobor
Edna Iroha
Olajumoke Oladipo
Elizabeth Onifade
Oyetunji O Soriyan
Adebola O Akinsulie
Edamisan O Temiye
Chinyere Ezeaka
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of the International AIDS Society / Issue 1/2010
Electronic ISSN: 1758-2652
DOI
https://doi.org/10.1186/1758-2652-13-17

Other articles of this Issue 1/2010

Journal of the International AIDS Society 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.